Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

Australian startup All G has secured A$10M ($6.6M) and signed a joint venture with Armor Protéines to expand production of ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

DNA nanostructures are exciting new biomedical tools with myriad potential in treatment, diagnosis and disease prevention.

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

High-resolution imaging has revealed the internal layout of chromatin condensates, showing how DNA fibers fold and interact ...

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

The vaccine developers market shows significant opportunities through increased demand, collaborative partnerships, and ...